Advertisement
Advertisement
Trending on Urology Times
1
Contextualizing Cretostimogene in the Evolving Treatment Landscape
2
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
3
Integrating Biomarker Testing and Emerging Targeted Therapies in mCSPC
4
Narmina Khanmammadova, MD, discusses findings on pelvic floor therapy before HoLEP
5